Anti-TNF-α therapy, use of corticosteroids, and colectomy among paediatric and adolescent patients with ulcerative colitis: a nationwide study

被引：1
|
作者：
Lund, K. [1 ,2 ]
Larsen, M. D. [1 ]
Knudsen, T. [3 ,4 ]
Kjeldsen, J. [5 ,6 ]
Nielsen, R. G. [7 ,8 ]
Noergaard, B. M. [1 ,2 ]
机构：
[1] Odense Univ Hosp, Ctr Clin Epidemiol, Odense, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Res Unit Clin Epidemiol, Odense, Denmark
[3] Hosp Southwest Jutland, Dept Med, Esbjerg, Denmark
[4] Univ Southern Denmark, Inst Reg Hlth Sci, Ctr Southwest Jutland, Esbjerg, Denmark
[5] Odense Univ Hosp, Dept Med Gastroenterol S, Odense, Denmark
[6] Univ Southern Denmark, Dept Clin Res, Res Unit Med Gastroenterol, Odense, Denmark
[7] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark
[8] Univ Southern Denmark, Dept Clin Res, Res Unit Pediat, Odense, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.772
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P648
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [1] The impact of anti-TNFα therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis-a nationwide study from 1995 to 2015
    Lund, Ken
    Larsen, Michael Due
    Knudsen, Torben
    Kjeldsen, Jens
    Nielsen, Rasmus Gaardskjaer
    Norgard, Bente Mertz
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (10) : 1077 - 1085
  • [2] Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis
    Yang, Xinhui
    Shi, Jintong
    Wang, Gaoyang
    Chen, Huifang
    Ye, Youqiong
    Zhong, Jie
    Wang, Zhengting
    INFLAMMATORY BOWEL DISEASES, 2023, : 1458 - 1469
  • [3] Mucosal healing with a second anti-TNF-α in patients with ulcerative colitis after the failure of the previous anti-TNF-α treatment
    Papa, A.
    Pugliese, D.
    D'Aversa, F.
    De Vitis, I.
    Landi, R.
    Guidi, L.
    Felice, C.
    Gerardi, V.
    Armuzzi, A.
    Gasbarrini, A.
    Rapaccini, G. L.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S414 - S414
  • [4] Screening and experimental validation of diagnostic gene in ulcerative colitis with anti-TNF-α therapy
    Chen, Yuan
    Li, Xinfang
    Sun, Ran
    Yang, Fan
    Tian, Weiliang
    Huang, Qian
    IUBMB LIFE, 2024, 76 (07) : 451 - 463
  • [5] Usefulness of drug-level monitoring in therapeutic guidance in patients with ulcerative colitis on anti-TNF-α maintenance therapy
    Oh, E. H.
    A-Ran, Y.
    Ye-Jee, K.
    Jeongseok, K.
    Namseok, N.
    Hyoung, P. Sang
    Dong-Hoon, Y.
    Jeong-Sik, B.
    Seung-Jae, M.
    Suk-Kyun, Y.
    Duk, Y. Byong
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S324 - S325
  • [6] A comparison of thiopurines vs. anti-TNF-α therapy in steroid-dependent ulcerative colitis
    Hosomi, S.
    Ohira, M.
    Yamagami, H.
    Nakata, R.
    Sugita, N.
    Nishida, Y.
    Itani, S.
    Yukawa, T.
    Kamata, N.
    Otani, K.
    Nagami, Y.
    Tanaka, F.
    Taira, K.
    Tanigawa, T.
    Watanabe, T.
    Fujiwara, Y.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S341 - S341
  • [7] A nationwide cohort study of colectomy rates for ulcerative colitis during the introduction of biologic therapy
    Worley, G.
    Almoudaris, A.
    Bassett, P.
    Segal, J.
    Akbar, A.
    Aylin, P.
    Faiz, O.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S65 - S66
  • [8] Changes of gut microbiome after anti-TNF-(sic) therapy and the prediction of clinical remission in patients with active ulcerative colitis
    Shin, S. Shin
    Oh, H. N.
    Moon, J. M.
    Joo, H. J.
    Sul, W. J.
    Choi, C. H.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 840 - 840
  • [9] Clinical Characteristics of Crohn's Disease and Ulcerative Colitis Patients Who Switched From an anti-TNF-α Agent or Natalizumab to Vedolizumab or an Alternative anti-TNF-α
    Liang, Huifang
    Manne, Sudhakar
    Shick, Jesse
    Yu, Shawn
    Fusco, Gregory
    Dolin, Paul
    GASTROENTEROLOGY, 2016, 150 (04) : S788 - S788
  • [10] Clinical characteristics of Crohn's disease and ulcerative colitis patients who switched from an anti-TNF-α agent or natalizumab to vedolizumab or an alternative anti-TNF-α
    Liang, H.
    Manne, S.
    Shick, J.
    Yu, S.
    Fusco, G.
    Dolin, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S445 - S446
12345